Robert Thomas Freeman Sells 30,500 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock in a transaction on Monday, November 11th. The stock was sold at an average price of $13.42, for a total transaction of $409,310.00. Following the completion of the transaction, the chief financial officer now directly owns 92,929 shares in the company, valued at $1,247,107.18. This represents a 24.71 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total value of $435,811.88.
• On Tuesday, October 29th, Robert Thomas Freeman sold 4,483 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.01, for a total value of $53,840.83.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.50, for a total value of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total value of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.66, for a total transaction of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.00, for a total transaction of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total transaction of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total transaction of $16,500.00.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $12.83 on Friday. The firm has a market cap of $2.46 billion, a PE ratio of -16.66 and a beta of 1.45. The firm has a fifty day moving average of $11.55 and a 200 day moving average of $9.31. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). The company had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. Alignment Healthcare’s quarterly revenue was up 51.6% on a year-over-year basis. During the same period in the previous year, the business earned ($0.19) EPS. As a group, research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C lifted its stake in Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after purchasing an additional 2,630,788 shares in the last quarter. William Blair Investment Management LLC lifted its position in Alignment Healthcare by 94.4% during the second quarter. William Blair Investment Management LLC now owns 3,104,681 shares of the company’s stock worth $24,279,000 after buying an additional 1,507,759 shares in the last quarter. Hood River Capital Management LLC boosted its stake in Alignment Healthcare by 49.6% during the first quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock worth $14,487,000 after buying an additional 968,637 shares during the last quarter. Royce & Associates LP purchased a new stake in Alignment Healthcare in the 3rd quarter valued at $3,782,000. Finally, Renaissance Technologies LLC increased its stake in shares of Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company’s stock worth $12,245,000 after acquiring an additional 225,000 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ALHC. Robert W. Baird lifted their price objective on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. Piper Sandler reissued an “overweight” rating and issued a $10.00 price target (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. UBS Group upped their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. KeyCorp initiated coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, TD Cowen increased their price target on shares of Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $10.33.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.